A Role for Common Genomic Variants in the Assessment of Familial Breast Cancer
Sarah Sawyer(Natera (United States)), Paul A. James(The Royal Melbourne Hospital), Joanne McKinley(Peter MacCallum Cancer Centre), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Geoffrey J. Lindeman(The University of Melbourne), David D.L. Bowtell(The University of Melbourne), Jonathan Beesley(The University of Melbourne), Marion Harris(Peter MacCallum Cancer Centre), Gillian Mitchell(Peter MacCallum Cancer Centre), Alison H. Trainer(Peter MacCallum Cancer Centre)
Cited by 90
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
|The Lancet|2010|1.6k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k